NeuroGlove Revenue

About NeuroGlove

NeuroGlove, Inc. was founded by internationally recognized neurosurgeon, Dr. Eric Nussbaum, in collaboration with biotech startup expert, Tom Harold. Based in Minneapolis Minnesota, the company focuses on non-invasive treatments for neurological illnesses including stroke, Parkinson’s disease, anxiety disorders, and traumatic brain injury. The company’s flagship device utilizes pneumatic peripheral sensory stimulation to activate various areas of the brain, encouraging neuronal re-organization and learning. Our initial clinical studies demonstrated safety in the setting of acute stroke and suggested that NeuroGlove can improve local cerebral blood flow in select patients. Clinical trials are underway to evaluate efficacy of our different devices in a variety of settings. We anticipate commercial availability of our products in the last quarter of 2023. Dr. Eric Nussbaum is a neurovascular and skull base surgeon who has authored numerous scientific publications and has been invited to lecture at neurosurgical centers and conferences throughout the country. Tom Harold has successfully led several early biotech companies. Under their joint leadership, NeuroGlove, Inc. is committed to developing novel, non-invasive therapeutic options for patients with neurological illnesses and combating the current mental health crisis. A novel device for accelerating healing/recovery from neurological disorders including stroke, traumatic brain injury, Parkinson’s, PTSD, Anxiety, Depression, TBI and more Our Clinical Evidence is Dramatically Positive and Statistically Significant For more information, please contact us at outreach@neuroglove.net Instagram https://www.instagram.com/neuroglove/

View contact profiles from NeuroGlove